市场调查报告书
商品编码
1305924
肾功能检测市场 - 按产品类型(浸渍棒、试剂、一次性用品)、按检测类型(尿液检测、血液检测)、按终端用途(医院、诊断实验室)划分,2023 - 2032年Kidney Function Tests Market - By Product Type (Dipsticks, Reagents, Disposables), By Test Type (Urine Tests, Blood Tests), By End-use (Hospitals, Diagnostic Laboratories), 2023 - 2032 |
到2032年,全球肾功能检测市场规模将大幅扩大。日益增长的老年人群对肾脏疾病的易感性增加了对肾功能检测的需求。据世界卫生组织预测,到2040年,中国60岁及以上人口将达到4.02亿。此外,蓬勃发展的医疗保健基础设施以及人们对肾脏疾病日益增长的认识也为该行业带来了增长机会。2022年8月,美国卫生与公众服务部宣布投资约6000万美元加强医疗卫生队伍建设。
整个肾功能检测市场根据产品、检测方法、终端用途和地区进行分类。
根据产品分类,一次性产品的行业价值将在2032年前大幅增长。一次性肾功能检测试剂盒的高精确度和高准确性可提高肌酐、血尿素氮(BUN)和电解质水平等各种参数的测量水平,因此更受青睐。此外,一次性使用简便,简化了检测过程,节省了时间,提高了临床工作效率。它们无需专门的实验室设备、试剂和熟练人员,从而降低了总体检测成本。
根据检测项目的不同,到2032年,血液检测领域的产值将大幅增长。人们对肾功能障碍早期检测和诊断的认识不断提高,增加了对血液化验的需求。此外,慢性肾脏病发病率的上升也进一步推动了对此类检测的需求。定期血液化验有助于跟踪疾病进展、评估治疗效果并指导管理决策。
根据最终用途,从2023年到2032年,医院领域的行业份额将以显著的复合年增长率增长。熟练医护人员的高可用性增加了患者到医院进行快速肾功能检测的人数。这些机构越来越多地配备现代化诊断设备,以提高患者的治疗效果。此外,政府对医院基础设施的投资激增也为该细分市场的增长创造了大量机会。
从区域角度来看,2023年至2032年,亚太地区肾功能检测市场份额将以显著的复合年增长率增长。肾脏疾病发病率的上升增加了该地区对肾功能检测的需求。此外,快速发展的医疗基础设施也为区域扩张带来了增长机会。根据IBEF的数据,在2023-24年的联邦预算中,政府向卫生和家庭福利部拨款107.6亿美元。
Global Kidney Function Tests Market size will expand substantially through 2032. Growing geriatric population's susceptibility to kidney disorders has increased the need for kidney function tests. As per WHO, in China, the population of people aged 60 years and over will reach 402 million by 2040. Moreover, flourishing healthcare infrastructure coupled with growing awareness about kidney disorders is presenting growth opportunities to the industry. In August 2022, the U.S. Department of Health and Human Services announced an investment of around USD 60 million to strengthen the healthcare workforce.
The overall kidney function tests market is categorized based on product, test, end-use, and region.
Based on the product, industry value from the disposables segment will register huge significant gains through 2032. High accuracy and precision of disposables allow for enhanced measurement of various parameters, such as creatinine, blood urea nitrogen (BUN), and electrolyte levels, favoring their adoption. Additionally, the simplicity of disposables streamlines the testing process, saves time, and enhances workflow efficiency in clinical settings. They eliminate the need for specialized laboratory equipment, reagents, and skilled personnel, reducing overall testing costs.
Based on the test, industry value from the blood tests segment will register huge gains through 2032. Growing awareness about the early detection and diagnosis of kidney dysfunction has increased the need for blood tests. Moreover, the rising prevalence of chronic kidney disease has further propelled the demand for such tests for the early detection of the condition. Regular blood tests help track disease progression, assess treatment efficacy, and guide management decisions.
Based on the end-use, industry share from the hospitals segment will grow at a notable CAGR from 2023 to 2032. High availability of skilled healthcare professionals has increased patient footfall in hospitals for rapid kidney function tests. These facilities are increasingly getting equipped with modern diagnostic devices for enhanced patient outcomes. Moreover, surging investments by the government in hospital infrastructure is further creating a plethora of opportunities for segment growth.
From the regional perspective, the Asia Pacific kidney function tests market share will grow at a notable CAGR from 2023 to 2032. Rising prevalence of kidney disorders has increased the need for kidney function tests in the region. Moreover, rapidly expanding healthcare infrastructure is presenting growth opportunities for regional expansion. As per IBEF, in the Union Budget 2023-24, the government awarded USD 10.76 billion to the Ministry of Health and Family Welfare.